Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multifocal Breast Carcinoma”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04457596
What this trial is testing

T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8HER2 Positive Breast Carcinoma+4 more
Alliance for Clinical Trials in Oncology 1,056
Not applicableNot Yet RecruitingNCT07677956
What this trial is testing

Safety of Breast-Conserving Surgery for Multifocal or Multicentric Breast Cancer

Who this might be right for
Breast Cancer
The First Affiliated Hospital with Nanjing Medical University 100
Early research (Phase 1)Study completedNCT04481113
What this trial is testing

Abemaciclib and Niraparib Before Surgery for the Treatment of Hormone Receptor Positive HER2 Negative Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more
OHSU Knight Cancer Institute 8
Testing effectiveness (Phase 2)Study completedNCT00417495
What this trial is testing

Sentinel Lymph Node Technique in Multifocal Breast Cancer

Who this might be right for
Breast Cancer
Centre Oscar Lambret 216
Not applicableUnknownNCT04656639
What this trial is testing

Diffusion-Weighted MRI for Diagnosis of Multifocal, Multicentric Breast Cancer

Who this might be right for
Breast Cancer
Seoul National University Hospital 580
Early research (Phase 1)Ended earlyNCT03128619
What this trial is testing

Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer

Who this might be right for
Estrogen Receptor PositiveHER2/Neu NegativeInvasive Breast Carcinoma+14 more
Jonsson Comprehensive Cancer Center 10
Large-scale testing (Phase 3)Active Not RecruitingNCT01272037
What this trial is testing

Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer

Who this might be right for
Breast Ductal Carcinoma In SituInvasive Breast CarcinomaMulticentric Breast Carcinoma+2 more
National Cancer Institute (NCI) 5,018
Not applicableStudy completedNCT00957099
What this trial is testing

Comparison Study of Breast Computed Tomography (CT) With Magnetic Resonance Imaging (MRI)

Who this might be right for
Breast Cancer
Emory University 2
Not applicableNot Yet RecruitingNCT06475066
What this trial is testing

Clinical Effectiveness of CEM in Diagnosis of Additional Findings at Preoperative Breast Magnetic Resonance Imaging

Who this might be right for
Breast Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 320
Not applicableStudy completedNCT06103032
What this trial is testing

Survival of BCS vs Mx in Asymptomatic Screen-detected NPBC

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 1,020
Not applicableUnknownNCT03900299
What this trial is testing

Evaluating New Surgical Technique in Management of Female Patients With Operable Multifocal Breast Cancer

Who this might be right for
Breast Cancer
Alexandria University 114